日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2011/04/04 | 1,061 | 1,066 | 1,045 | 1,048 | ±0 | ±0% | 147,000 |
| 2011/04/01 | 1,091 | 1,094 | 1,034 | 1,048 | -19 | -1.8% | 182,000 |
| 2011/03/31 | 1,065 | 1,068 | 1,057 | 1,067 | +10 | +0.9% | 108,000 |
| 2011/03/30 | 1,050 | 1,057 | 1,039 | 1,057 | +7 | +0.7% | 94,000 |
| 2011/03/29 | 1,049 | 1,052 | 1,044 | 1,050 | +15 | +1.4% | 85,000 |
| 2011/03/28 | 1,046 | 1,046 | 1,025 | 1,035 | -10 | -1% | 96,000 |
| 2011/03/25 | 1,059 | 1,059 | 1,035 | 1,045 | +15 | +1.5% | 125,000 |
| 2011/03/24 | 1,065 | 1,076 | 1,030 | 1,030 | +31 | +3.1% | 171,000 |
| 2011/03/23 | 1,013 | 1,026 | 996 | 999 | +1 | +0.1% | 104,000 |
| 2011/03/22 | 1,001 | 1,004 | 985 | 998 | +12 | +1.2% | 137,000 |
| 2011/03/18 | 970 | 999 | 963 | 986 | +22 | +2.3% | 200,000 |
| 2011/03/17 | 900 | 975 | 883 | 964 | +10 | +1% | 535,000 |
| 2011/03/16 | 930 | 954 | 890 | 954 | +129 | +15.6% | 381,000 |
| 2011/03/15 | 971 | 971 | 706 | 825 | -176 | -17.6% | 624,000 |
| 2011/03/14 | 1,050 | 1,079 | 990 | 1,001 | -81 | -7.5% | 167,000 |
| 2011/03/11 | 1,088 | 1,104 | 1,079 | 1,082 | -21 | -1.9% | 312,000 |
| 2011/03/10 | 1,112 | 1,121 | 1,100 | 1,103 | -26 | -2.3% | 127,000 |
| 2011/03/09 | 1,127 | 1,131 | 1,120 | 1,129 | +3 | +0.3% | 129,000 |
| 2011/03/08 | 1,132 | 1,143 | 1,126 | 1,126 | -5 | -0.4% | 138,000 |
| 2011/03/07 | 1,147 | 1,154 | 1,126 | 1,131 | -16 | -1.4% | 182,000 |
| 2011/03/04 | 1,181 | 1,181 | 1,145 | 1,147 | -4 | -0.3% | 423,000 |
| 2011/03/03 | 1,096 | 1,175 | 1,093 | 1,151 | +85 | +8% | 861,000 |
| 2011/03/02 | 1,060 | 1,069 | 1,054 | 1,066 | -6 | -0.6% | 242,000 |
| 2011/03/01 | 1,079 | 1,085 | 1,069 | 1,072 | -4 | -0.4% | 123,000 |
| 2011/02/28 | 1,073 | 1,079 | 1,065 | 1,076 | +3 | +0.3% | 117,000 |
| 2011/02/25 | 1,080 | 1,082 | 1,063 | 1,073 | -14 | -1.3% | 164,000 |
| 2011/02/24 | 1,100 | 1,100 | 1,084 | 1,087 | -15 | -1.4% | 117,000 |
| 2011/02/23 | 1,108 | 1,113 | 1,102 | 1,102 | -6 | -0.5% | 72,000 |
| 2011/02/22 | 1,113 | 1,120 | 1,107 | 1,108 | -5 | -0.4% | 133,000 |
| 2011/02/21 | 1,119 | 1,119 | 1,112 | 1,113 | -2 | -0.2% | 45,000 |
| 2011/02/18 | 1,120 | 1,120 | 1,112 | 1,115 | +2 | +0.2% | 90,000 |
| 2011/02/17 | 1,115 | 1,119 | 1,109 | 1,113 | -7 | -0.6% | 207,000 |
| 2011/02/16 | 1,131 | 1,131 | 1,108 | 1,120 | -3 | -0.3% | 163,000 |
| 2011/02/15 | 1,115 | 1,129 | 1,114 | 1,123 | +8 | +0.7% | 127,000 |
| 2011/02/14 | 1,128 | 1,128 | 1,110 | 1,115 | -4 | -0.4% | 138,000 |
| 2011/02/10 | 1,112 | 1,122 | 1,106 | 1,119 | +7 | +0.6% | 235,000 |
| 2011/02/09 | 1,105 | 1,122 | 1,103 | 1,112 | -11 | -1% | 300,000 |
| 2011/02/08 | 1,140 | 1,145 | 1,115 | 1,123 | -23 | -2% | 262,000 |
| 2011/02/07 | 1,142 | 1,148 | 1,134 | 1,146 | -2 | -0.2% | 137,000 |
| 2011/02/04 | 1,137 | 1,150 | 1,136 | 1,148 | +10 | +0.9% | 106,000 |
| 2011/02/03 | 1,138 | 1,141 | 1,130 | 1,138 | -6 | -0.5% | 79,000 |
| 2011/02/02 | 1,143 | 1,152 | 1,140 | 1,144 | ±0 | ±0% | 166,000 |
| 2011/02/01 | 1,150 | 1,150 | 1,139 | 1,144 | -10 | -0.9% | 93,000 |
| 2011/01/31 | 1,157 | 1,157 | 1,140 | 1,154 | -3 | -0.3% | 115,000 |
| 2011/01/28 | 1,152 | 1,164 | 1,150 | 1,157 | +2 | +0.2% | 202,000 |
| 2011/01/27 | 1,160 | 1,162 | 1,149 | 1,155 | -7 | -0.6% | 102,000 |
| 2011/01/26 | 1,172 | 1,172 | 1,159 | 1,162 | -10 | -0.9% | 105,000 |
| 2011/01/25 | 1,158 | 1,181 | 1,152 | 1,172 | +14 | +1.2% | 233,000 |
| 2011/01/24 | 1,141 | 1,160 | 1,140 | 1,158 | +14 | +1.2% | 163,000 |
| 2011/01/21 | 1,140 | 1,157 | 1,135 | 1,144 | -3 | -0.3% | 268,000 |
3501～
3550
件表示中 / 3747件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 322,000円 | +8.0% | -15.3% | 3.85% | 9.04倍 | 0.88倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 久光薬 | 395,600円 | +5.8% | +1.2% | 3.03% | 12.81倍 | 1.02倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ツムラ | 365,000円 | +3.8% | -19.9% | 3.73% | 11.86倍 | 0.91倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サワイＧＨＤ | 195,300円 | +5.9% | +684.6% | 2.82% | 12.96倍 | 1.30倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| ペプチド | 168,500円 | +5.0% | +1.5% | 0.00% | 14.41倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
